R. E. Glover

1.7k total citations · 1 hit paper
45 papers, 853 citations indexed

About

R. E. Glover is a scholar working on Applied Microbiology and Biotechnology, General Health Professions and Economics and Econometrics. According to data from OpenAlex, R. E. Glover has authored 45 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Applied Microbiology and Biotechnology, 11 papers in General Health Professions and 7 papers in Economics and Econometrics. Recurrent topics in R. E. Glover's work include Antibiotic Use and Resistance (16 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Primary Care and Health Outcomes (5 papers). R. E. Glover is often cited by papers focused on Antibiotic Use and Resistance (16 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Primary Care and Health Outcomes (5 papers). R. E. Glover collaborates with scholars based in United Kingdom, United States and Canada. R. E. Glover's co-authors include Gwenan M. Knight, Clare Chandler, Christopher Finn McQuaid, Karin Gallandat, Sam Willcocks, Quentin J. Leclerc, Rumina Hasan, Esther van Kleef, Naomi M. Fuller and Ioana D. Olaru and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

R. E. Glover

37 papers receiving 824 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antimicrobial resistance and COVID-19: Intersections and implications

2021 240 citations Gwenan M. Knight, R. E. Glover et al. eLife profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. E. Glover United Kingdom	13	220	195	165	142	127	45	853
Amesh A. Adalja United States	18	344 1.6×	78 0.4×	81 0.5×	159 1.1×	45 0.4×	56	1.1k
Charlotte Jackson United Kingdom	20	467 2.1×	176 0.9×	258 1.6×	681 4.8×	63 0.5×	43	1.3k
Md. Ariful Islam Bangladesh	17	128 0.6×	97 0.5×	70 0.4×	176 1.2×	57 0.4×	56	687
Kevin Escandón-Vargas Colombia	13	157 0.7×	171 0.9×	48 0.3×	101 0.7×	234 1.8×	33	726
İmran Hasanoğlu Türkiye	13	512 2.3×	56 0.3×	145 0.9×	130 0.9×	42 0.3×	63	1.1k
Abdullatif Al‐Khal Qatar	15	309 1.4×	43 0.2×	99 0.6×	105 0.7×	63 0.5×	50	656
Menglan Zhou China	17	450 2.0×	64 0.3×	220 1.3×	428 3.0×	247 1.9×	49	1.4k
Jacinda C. Abdul‐Mutakabbir United States	16	240 1.1×	102 0.5×	33 0.2×	135 1.0×	234 1.8×	64	735
Jia Hu Canada	17	493 2.2×	33 0.2×	151 0.9×	238 1.7×	67 0.5×	70	1.3k
Itaru Nakamura Japan	19	429 1.9×	23 0.1×	164 1.0×	215 1.5×	73 0.6×	95	1.3k

Countries citing papers authored by R. E. Glover

Since Specialization

Citations

This map shows the geographic impact of R. E. Glover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Glover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Glover more than expected).

Fields of papers citing papers by R. E. Glover

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. E. Glover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Glover. The network helps show where R. E. Glover may publish in the future.

Co-authorship network of co-authors of R. E. Glover

This figure shows the co-authorship network connecting the top 25 collaborators of R. E. Glover. A scholar is included among the top collaborators of R. E. Glover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. E. Glover. R. E. Glover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Glover, R. E., Mirza Lalani, Thomas Allen, et al.. (2025). A mixed methods protocol for an impact and implementation evaluation of the Pharmacy First Services for management of common conditions in England. International Journal of Pharmacy Practice. 33(2). 152–161. 1 indexed citations

Mantzourani, Efi, Haroon Ahmed, Rebecca Cannings‐John, et al.. (2025). Comparison of antibiotic provision associated with acute sore throat symptom management in community pharmacies in Wales and England: a natural policy experiment. Journal of Antimicrobial Chemotherapy. 80(5). 1256–1260.

Bennani, Houda, et al.. (2024). Progress and Challenges: Implementation of the UK Antimicrobial Resistance National Action Plan 2019–2024 within the Beef Cattle Sub-Sector. Antibiotics. 13(9). 839–839.

Exley, Josephine, R. E. Glover, Sarah Orleans Reed, et al.. (2024). Governing Integrated Health and Social Care: An Analysis of Experiences in Three European Countries. International Journal of Integrated Care. 24(1). 9–9. 10 indexed citations

Lotfi, Tamara, Vivian Welch, Jordi Pardo Pardo, et al.. (2024). Equity in evidence synthesis: You can't play on broken strings. SHILAP Revista de lepidopterología. 2(6). e12091–e12091.

Glover, R. E., Andrew C. Singer, Adam P. Roberts, & Claas Kirchhelle. (2023). Why is the UK subscription model for antibiotics considered successful?. The Lancet Microbe. 4(11). e852–e853. 7 indexed citations

Dewidar, Omar, Alba Antequera, Andrea C. Tricco, et al.. (2022). Methodological guidance for incorporating equity when informing rapid-policy and guideline development. Journal of Clinical Epidemiology. 150. 142–153. 19 indexed citations

Glover, R. E., Andrew C. Singer, Adam P. Roberts, & Claas Kirchhelle. (2022). The antibiotic subscription model: fostering innovation or repackaging old drugs?. The Lancet Microbe. 4(1). e2–e3. 14 indexed citations

McCaul, Michael, David Tovey, Taryn Young, et al.. (2022). Resources supporting trustworthy, rapid and equitable evidence synthesis and guideline development: results from the COVID-19 evidence network to support decision-making (COVID-END). Journal of Clinical Epidemiology. 151. 88–95. 14 indexed citations

10.

Knight, Gwenan M., R. E. Glover, Christopher Finn McQuaid, et al.. (2021). Antimicrobial resistance and COVID-19: Intersections and implications. eLife. 10. 240 indexed citations breakdown →

11.

Glover, R. E., Andrew C. Singer, Adam P. Roberts, & Claas Kirchhelle. (2021). NIMble innovation - a networked model for public antibiotic trials. SocArXiv (OSF Preprints). 1 indexed citations

12.

Glover, R. E., et al.. (2021). Vaccinating against covid-19 in people who report allergies. BMJ. 372. n120–n120. 23 indexed citations

13.

Glover, R. E., Andrew C. Singer, Adam P. Roberts, & Claas Kirchhelle. (2021). NIMble innovation—a networked model for public antibiotic trials. The Lancet Microbe. 2(11). e637–e644. 8 indexed citations

14.

Glover, R. E., Gwenan M. Knight, & Clare Chandler. (2021). Antimicrobial resistance at the G7. BMJ. 373. n1417–n1417. 9 indexed citations

15.

Glover, R. E., May CI van Schalkwyk, Elie A. Akl, et al.. (2020). A framework for identifying and mitigating the equity harms of COVID-19 policy interventions. Journal of Clinical Epidemiology. 128. 35–48. 121 indexed citations

16.

Glover, R. E., et al.. (2019). Antibiotic resistance: don’t blame patients. BMJ. 364. l1218–l1218. 7 indexed citations

17.

Knight, Gwenan M., Nicholas G. Davies, Caroline Colijn, et al.. (2019). Mathematical modelling for antibiotic resistance control policy: do we know enough?. BMC Infectious Diseases. 19(1). 1011–1011. 48 indexed citations

18.

Vyakarnam, Annapurna, et al.. (1988). Cytolysis by Cloned Helper T Cells: Induction by Specific Antigen or by Anti‐CD3 Hybrid Antibodies. Scandinavian Journal of Immunology. 27(6). 635–644. 1 indexed citations

19.

Glover, R. E. & Lise Trottier. (1978). Pharmacy involvement in the evaluation of drug allergies.. PubMed. 30(2). 38–44. 5 indexed citations

20.

Jennings, A.R. & R. E. Glover. (1952). Enzootic Pneumonia in Calves. Journal of Comparative Pathology and Therapeutics. 62. 6–22. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact